1058d EFFICACY AND SAFETY OF THE FIRST CO-ANTIBODY THERAPY, JNJ-78934804, IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS REFRACTORY TO SYSTEMIC THERAPIES

Gastrointestinal Endoscopy 2026

View at publisher
Authors: Maria José Abreu, Bruce E. Sands, Séverine Vermeire, Remo Panaccione, Gregory Thomas Moore, Raja Atreya, John Lynch, Melissa G. Marko, Eun Suk Jung, Siyka Alexandrova, Hayley Perry, Marion Vetter
+1 more Julián Panés
DOI: 10.1016/s0016-5107(26)06687-3
Cited by: 1

Fields of Study & Subjects

Inflammatory Bowel Disease Microscopic Colitis Hidradenitis Suppurativa and Treatments

Publication details

Journal / source
Gastrointestinal Endoscopy
Publisher
Elsevier BV
Volume
103
Issue
5
Pages
S–2857
Publication date
1 May 2026
Language
EN